NCT05489068 Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment
| NCT ID | NCT05489068 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of New Mexico |
| Condition | Substance-Related Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2022-03-16 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2022-03-16 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.
Eligibility Criteria
Inclusion Criteria (client participants): * English-speaking adults seeking treatment for alcohol or other drug use at one of two outpatient addiction treatment programs * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures * Physically withdrawn from alcohol or other drugs Inclusion Criteria (personnel participants): * English-speaking adults currently employed at one of the two outpatient addiction treatment programs * Provision of electronic informed consent Exclusion Criteria (client participants): * Experiencing severe withdrawal symptoms * Actively psychotic, manic, and/or suicidal Exclusion Criteria (personnel participants): * current position: facility owner or clinical director
Contact & Investigator
Margo Hurlocker, PhD
PRINCIPAL INVESTIGATOR
University of New Mexico
Frequently Asked Questions
Who can join the NCT05489068 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Substance-Related Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05489068 currently recruiting?
Yes, NCT05489068 is actively recruiting participants. Contact the research team at mhurlocker@unm.edu for enrollment information.
Where is the NCT05489068 trial being conducted?
This trial is being conducted at Albuquerque, United States.
Who is sponsoring the NCT05489068 clinical trial?
NCT05489068 is sponsored by University of New Mexico. The principal investigator is Margo Hurlocker, PhD at University of New Mexico. The trial plans to enroll 150 participants.